A critical role for interleukin-1β in the progression of autoimmune diseases

International Immunopharmacology

Volumn 17, Issue 3, 2013, Pages 658-669

  Zhao, Ruijuan ^a   Zhou, Hongyan ^a   Su, Shao Bo ^a  

^a SUN YAT SEN UNIVERSITY   (China)

Author keywords

Autoimmune diseases; Biological therapy; Interleukin 1

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; APILIMOD; CANAKINUMAB; CORTICOSTEROID; DEXAMETHASONE; GEVOKIZUMAB; INTERLEUKIN 1BETA; METHOTREXATE; RECOMBINANT INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; RILONACEPT;

ARTICLE; AUTOIMMUNE DISEASE; CLINICAL TRIAL; DISEASE COURSE; GRAVES DISEASE; HASHIMOTO DISEASE; HEPATITIS; HUMAN; INNER EAR DISEASE; INSULIN DEPENDENT DIABETES MELLITUS; KIDNEY DISEASE; MULTIPLE SCLEROSIS; MYOCARDITIS; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; RHEUMATIC DISEASE; RHEUMATOID ARTHRITIS; SINGLE DRUG DOSE; SYNDROME; SYSTEMIC LUPUS ERYTHEMATOSUS; TARGET CELL; THYROID DISEASE; UVEITIS;

AUTOIMMUNE DISEASES; BIOLOGICAL THERAPY; INTERLEUKIN-1Β;

ANIMALS; AUTOIMMUNE DISEASES; HUMANS; INTERLEUKIN-1BETA;

EID: 84883676742     PISSN: 15675769     EISSN: 18781705     Source Type: Journal    
DOI: 10.1016/j.intimp.2013.08.012     Document Type: Review

References (187)

1. I. Dujmovic, K. Mangano, T. Pekmezovic, C. Quattrocchi, S. Mesaros, and N. Stojsavljevic The analysis of IL-1 beta and its naturally occurring inhibitors in multiple sclerosis: the elevation of IL-1 receptor antagonist and IL-1 receptor type II after steroid therapy J Neuroimmunol 207 1-2 2009 101 106
2. I. Gery, and B.H. Waksman Potentiation of the T-lymphocyte response to mitogens. II. The cellular source of potentiating mediator(s) J Exp Med 136 1 1972 143 155
3. I. Gery, R.K. Gershon, and B.H. Waksman Potentiation of the T-lymphocyte response to mitogens. I. The responding cell J Exp Med 136 1 1972 128 142
4. C.A. Dinarello, L. Renfer, and S.M. Wolff Human leukocytic pyrogen: purification and development of a radioimmunoassay Proc Natl Acad Sci U S A 74 10 1977 4624 4627 (Pubitemid 8225178)
5. A. Steinkasserer, N.K. Spurr, S. Cox, P. Jeggo, and R.B. Sim The human IL-1 receptor antagonist gene (IL1RN) maps to chromosome 2q14-q21, in the region of the IL-1 alpha and IL-1 beta loci Genomics 13 3 1992 654 657
6. A. Kluczyk, I.Z. Siemiona, and Z. Wieczorek The "two-headed" peptide inhibitors of interleukin-1 action Peptides 21 9 2000 1411 1420
7. D. Tripodi, F. Conti, M. Rosati, G. Maccauro, A. Saggini, and E. Cianchetti IL-36 a new member of the IL-1 family cytokines J Biol Regul Homeost Agents 26 1 2012 7 14
8. T. Pecaric-Petkovic, S.A. Didichenko, S. Kaempfer, N. Spiegl, and C.A. Dahinden Human basophils and eosinophils are the direct target leukocytes of the novel IL-1 family member IL-33 Blood 113 7 2009 1526 1534
9. D. Boraschi, D. Lucchesi, S. Hainzl, M. Leitner, E. Maier, and D. Mangelberger IL-37: a new anti-inflammatory cytokine of the IL-1 family Eur Cytokine Netw 22 3 2011 127 147
10. F.L. van de Veerdonk, A.K. Stoeckman, G. Wu, A.N. Boeckermann, T. Azam, and M.G. Netea IL-38 binds to the IL-36 receptor and has biological effects on immune cells similar to IL-36 receptor antagonist Proc Natl Acad Sci U S A 109 8 2012 3001 3005
11. A. Johnston, X. Xing, A.M. Guzman, M. Riblett, C.M. Loyd, and N.L. Ward IL-1F5, -F6, -F8, and -F9: a novel IL-1 family signaling system that is active in psoriasis and promotes keratinocyte antimicrobial peptide expression J Immunol 186 4 2011 2613 2622
12. N.A. Thornberry, H.G. Bull, J.R. Calaycay, K.T. Chapman, A.D. Howard, and M.J. Kostura A novel heterodimeric cysteine protease is required for interleukin-1 beta processing in monocytes Nature 356 6372 1992 768 774
13. C. Andrei, C. Dazzi, L. Lotti, M.R. Torrisi, G. Chimini, and A. Rubartelli The secretory route of the leaderless protein interleukin 1beta involves exocytosis of endolysosome-related vesicles Mol Biol Cell 10 5 1999 1463 1475 (Pubitemid 29230902)
14. F. Martinon, K. Burns, and J. Tschopp The inflammasome: a molecular platform triggering activation of inflammatory caspases and processing of proIL-beta Mol Cell 10 2 2002 417 426 (Pubitemid 35007355)
15. G. Lopez-Castejon, and D. Brough Understanding the mechanism of IL-1beta secretion Cytokine Growth Factor Rev 22 4 2011 189 195
16. V.A. Rathinam, S.K. Vanaja, and K.A. Fitzgerald Regulation of inflammasome signaling Nat Immunol 13 4 2012 333 342
17. B.R. Barker, D.J. Taxman, and J.P. Ting Cross-regulation between the IL-1beta/IL-18 processing inflammasome and other inflammatory cytokines Curr Opin Immunol 23 5 2011 591 597
18. M. Lamkanfi, L.V. Walle, and T.D. Kanneganti Deregulated inflammasome signaling in disease Immunol Rev 243 1 2011 163 173
19. D. Burger, J.M. Dayer, G. Palmer, and C. Gabay Is IL-1 a good therapeutic target in the treatment of arthritis? Best Pract Res Clin Rheumatol 20 5 2006 879 896 (Pubitemid 44382385)
20. L.C. Hsu, S.R. Ali, S. McGillivray, P.H. Tseng, S. Mariathasan, and E.W. Humke A NOD2-NALP1 complex mediates caspase-1-dependent IL-1beta secretion in response to Bacillus anthracis infection and muramyl dipeptide Proc Natl Acad Sci U S A 105 22 2008 7803 7808 (Pubitemid 351872719)
21. O. Gross, H. Poeck, M. Bscheider, C. Dostert, N. Hannesschlager, and S. Endres Syk kinase signalling couples to the Nlrp3 inflammasome for anti-fungal host defence Nature 459 7245 2009 433 436
22. T.D. Kanneganti, M. Body-Malapel, A. Amer, J.H. Park, J. Whitfield, and L. Franchi Critical role for Cryopyrin/Nalp3 in activation of caspase-1 in response to viral infection and double-stranded RNA J Biol Chem 281 48 2006 36560 36568 (Pubitemid 46042123)
23. C.A. Dinarello Interleukin-1 and interleukin-1 receptor antagonist Nutrition 11 5 Suppl. 1995 492 494 (Pubitemid 26006209)
24. C.A. Dinarello Interleukin-1 and interleukin-1 receptor antagonist production during haemodialysis: which cytokine is a surrogate marker for dialysis-related complications? Nephrol Dial Transplant 10 Suppl. 3 1995 25 28
25. C.A. Dinarello Biologic basis for interleukin-1 in disease Blood 87 6 1996 2095 2147 (Pubitemid 26086851)
26. C.A. Dinarello The IL-1 family and inflammatory diseases Clin Exp Rheumatol 20 5 Suppl. 27 2002 S1 S13
27. E. Contassot, H.D. Beer, and L.E. French Interleukin-1, inflammasomes, autoinflammation and the skin Swiss Med Wkly 142 2012 w13590
28. M.A. Garcia-Gonzalez, M.A. Aisa, M. Strunk, R. Benito, E. Piazuelo, and P. Jimenez Relevance of IL-1 and TNF gene polymorphisms on interleukin-1beta and tumor necrosis factor-alpha gastric mucosal production Hum Immunol 70 11 2009 935 945
29. K. Onozaki, K. Matsushima, B.B. Aggarwal, and J.J. Oppenheim Human interleukin 1 is a cytocidal factor for several tumor cell lines J Immunol 135 6 1985 3962 3968 (Pubitemid 16250376)
30. L. Gramantieri, A. Casali, D. Trere, S. Gaiani, F. Piscaglia, and P. Chieco Imbalance of IL-1 beta and IL-1 receptor antagonist mRNA in liver tissue from hepatitis C virus (HCV)-related chronic hepatitis Clin Exp Immunol 115 3 1999 515 520 (Pubitemid 29130369)
31. J.F. Camargo, P.A. Correa, J. Castiblanco, and J.M. Anaya Interleukin-1beta polymorphisms in Colombian patients with autoimmune rheumatic diseases Genes Immun 5 8 2004 609 614 (Pubitemid 40045298)
32. M.D. Wewers, H.A. Dare, A.V. Winnard, J.M. Parker, and D.K. Miller IL-1 beta-converting enzyme (ICE) is present and functional in human alveolar macrophages: macrophage IL-1 beta release limitation is ICE independent J Immunol 159 12 1997 5964 5972 (Pubitemid 127471532)
33. K. Aggelakis, F. Zacharaki, E. Dardiotis, G. Xiromerisiou, V. Tsimourtou, and S. Ralli Interleukin-1B and interleukin-1 receptor antagonist gene polymorphisms in Greek multiple sclerosis (MS) patients with bout-onset MS Neurol Sci 31 3 2010 253 257
34. M.R. Heitmeier, M. Arnush, A.L. Scarim, and J.A. Corbett Pancreatic beta-cell damage mediated by beta-cell production of interleukin-1. A novel mechanism for virus-induced diabetes J Biol Chem 276 14 2001 11151 11158 (Pubitemid 38089298)
35. A. Oberholzer, C. Oberholzer, and L.L. Moldawer Cytokine signaling - regulation of the immune response in normal and critically ill states Crit Care Med 28 4 Suppl. 2000 N3 N12
36. T. Sparre, U.B. Christensen, C.F. Gotfredsen, P.M. Larsen, S.J. Fey, and K. Hjerno Changes in expression of IL-1 beta influenced proteins in transplanted islets during development of diabetes in diabetes-prone BB rats Diabetologia 47 5 2004 892 908 (Pubitemid 38757004)
37. C.A. Dinarello Interleukin-1, interleukin-1 receptors and interleukin-1 receptor antagonist Int Rev Immunol 16 5-6 1998 457 499 (Pubitemid 28286181)
38. N.J. Rothwell, and G.N. Luheshi Interleukin 1 in the brain: biology, pathology and therapeutic target Trends Neurosci 23 12 2000 618 625 (Pubitemid 32007888)
39. H.C. Tseng, I.T. Lee, C.C. Lin, P.L. Chi, S.E. Cheng, and R.H. Shih IL-1beta promotes corneal epithelial cell migration by increasing MMP-9 expression through NF-kappaB- and AP-1-dependent pathways PLoS One 8 3 2013 e57955
40. A. Dunne, and L.A. O'Neill The interleukin-1 receptor/Toll-like receptor superfamily: signal transduction during inflammation and host defense Sci STKE 2003 171 2003 re3
41. E. Nishida, and Y. Gotoh The MAP kinase cascade is essential for diverse signal transduction pathways Trends Biochem Sci 18 4 1993 128 131 (Pubitemid 23105313)
42. M.C. Walsh, G.K. Kim, P.L. Maurizio, E.E. Molnar, and Y. Choi TRAF6 autoubiquitination-independent activation of the NFkappaB and MAPK pathways in response to IL-1 and RANKL PLoS One 3 12 2008 e4064
43. P.P. Lie, C.Y. Cheng, and D.D. Mruk The biology of interleukin-1: emerging concepts in the regulation of the actin cytoskeleton and cell junction dynamics Cell Mol Life Sci 69 4 2012 487 500
44. Z.P. Xia, L. Sun, X. Chen, G. Pineda, X. Jiang, and A. Adhikari Direct activation of protein kinases by unanchored polyubiquitin chains Nature 461 7260 2009 114 119
45. J. Chun, R.J. Choi, S. Khan, D.S. Lee, Y.C. Kim, and Y.J. Nam Alantolactone suppresses inducible nitric oxide synthase and cyclooxygenase-2 expression by down-regulating NF-kappaB, MAPK and AP-1 via the MyD88 signaling pathway in LPS-activated RAW 264.7 cells Int Immunopharmacol 14 4 2012 375 383
46. T. Persichini, N. Maio, M.C. di Patti, G. Rizzo, S. Toscano, and M. Colasanti Interleukin-1beta induces ceruloplasmin and ferroportin-1 gene expression via MAP kinases and C/EBPbeta, AP-1, and NF-kappaB activation Neurosci Lett 484 2 2010 133 138
47. D. Thanos, and T. Maniatis NF-kappa B: a lesson in family values Cell 80 4 1995 529 532
48. I.M. Verma, and J. Stevenson IkappaB kinase: beginning, not the end Proc Natl Acad Sci U S A 94 22 1997 11758 11760 (Pubitemid 27467787)
49. R. Chen, M. Li, Y. Zhang, Q. Zhou, and H.B. Shu The E3 ubiquitin ligase MARCH8 negatively regulates IL-1beta-induced NF-kappaB activation by targeting the IL1RAP coreceptor for ubiquitination and degradation Proc Natl Acad Sci U S A 109 35 2012 14128 14133
50. F. Guesdon, C.G. Knight, L.M. Rawlinson, and J. Saklatvala Dual specificity of the interleukin 1- and tumor necrosis factor-activated beta casein kinase J Biol Chem 272 48 1997 30017 30024 (Pubitemid 27512195)
51. S. Pathak, E. Goldofsky, E.X. Vivas, V.R. Bonagura, and A. Vambutas IL-1beta is overexpressed and aberrantly regulated in corticosteroid nonresponders with autoimmune inner ear disease J Immunol 186 3 2011 1870 1879
52. C. Galarza, D. Valencia, G.J. Tobon, L. Zurita, R.D. Mantilla, and R. Pineda-Tamayo Should rituximab be considered as the first-choice treatment for severe autoimmune rheumatic diseases? Clin Rev Allergy Immunol 34 1 2008 124 128
53. P.S. Burrage, K.S. Mix, and C.E. Brinckerhoff Matrix metalloproteinases: role in arthritis Front Biosci 11 2006 529 543 (Pubitemid 43258162)
54. F. Breedveld New tumor necrosis factor-alpha biologic therapies for rheumatoid arthritis Eur Cytokine Netw 9 3 1998 233 238 (Pubitemid 28510559)
55. C. Bansard, T. Lequerre, C. Derambure, O. Vittecoq, M. Hiron, and A. Daragon Gene profiling predicts rheumatoid arthritis responsiveness to IL-1Ra (anakinra) Rheumatology (Oxford) 50 2 2011 283 292
56. N.J. Olsen, and C.M. Stein New drugs for rheumatoid arthritis N Engl J Med 350 21 2004 2167 2179
57. J.S. Smolen, D. Aletaha, M. Koeller, M.H. Weisman, and P. Emery New therapies for treatment of rheumatoid arthritis Lancet 370 9602 2007 1861 1874 (Pubitemid 350180008)
58. W.B. van den Berg Anti-cytokine therapy in chronic destructive arthritis Arthritis Res 3 1 2001 18 26
59. R. Alten, H. Gram, L.A. Joosten, W.B. van den Berg, J. Sieper, and S. Wassenberg The human anti-IL-1 beta monoclonal antibody ACZ885 is effective in joint inflammation models in mice and in a proof-of-concept study in patients with rheumatoid arthritis Arthritis Res Ther 10 3 2008 R67
60. S. Miyata, Y. Ohkubo, and S. Mutoh A review of the action of tacrolimus (FK506) on experimental models of rheumatoid arthritis Inflamm Res 54 1 2005 1 9 (Pubitemid 40385335)
61. R. Lafyatis, E.F. Remmers, A.B. Roberts, D.E. Yocum, M.B. Sporn, and R.L. Wilder Anchorage-independent growth of synoviocytes from arthritic and normal joints. Stimulation by exogenous platelet-derived growth factor and inhibition by transforming growth factor-beta and retinoids J Clin Invest 83 4 1989 1267 1276 (Pubitemid 19113041)
62. J.A. Mengshol, M.P. Vincenti, C.I. Coon, A. Barchowsky, and C.E. Brinckerhoff Interleukin-1 induction of collagenase 3 (matrix metalloproteinase 13) gene expression in chondrocytes requires p38, c-Jun N-terminal kinase, and nuclear factor kappaB: differential regulation of collagenase 1 and collagenase 3 Arthritis Rheum 43 4 2000 801 811
63. J.A. Mengshol, M.P. Vincenti, and C.E. Brinckerhoff IL-1 induces collagenase-3 (MMP-13) promoter activity in stably transfected chondrocytic cells: requirement for Runx-2 and activation by p38 MAPK and JNK pathways Nucleic Acids Res 29 21 2001 4361 4372 (Pubitemid 33064776)
64. A.C. Schmucker, J.B. Wright, M.D. Cole, and C.E. Brinckerhoff Distal interleukin-1beta (IL-1beta) response element of human matrix metalloproteinase-13 (MMP-13) binds activator protein 1 (AP-1) transcription factors and regulates gene expression J Biol Chem 287 2 2012 1189 1197
65. X. Le Loet, D. Nordstrom, M. Rodriguez, A. Rubbert, P. Sarzi-Puttini, and J.M. Wouters Effect of anakinra on functional status in patients with active rheumatoid arthritis receiving concomitant therapy with traditional disease modifying antirheumatic drugs: evidence from the OMEGA Trial J Rheumatol 35 8 2008 1538 1544
66. A.A. den Broeder, E. de Jong, M.J. Franssen, M.E. Jeurissen, M. Flendrie, and F.H. van den Hoogen Observational study on efficacy, safety, and drug survival of anakinra in rheumatoid arthritis patients in clinical practice Ann Rheum Dis 65 6 2006 760 762 (Pubitemid 43799175)
67. S. Cohen, E. Hurd, J. Cush, M. Schiff, M.E. Weinblatt, and L.W. Moreland Treatment of rheumatoid arthritis with anakinra, a recombinant human interleukin-1 receptor antagonist, in combination with methotrexate: results of a twenty-four-week, multicenter, randomized, double-blind, placebo-controlled trial Arthritis Rheum 46 3 2002 614 624 (Pubitemid 34214243)
68. B. Bresnihan, and M. Cobby Clinical and radiological effects of anakinra in patients with rheumatoid arthritis Rheumatology (Oxford) 42 Suppl. 2 2003 ii22 ii28
69. M. Mertens, and J.A. Singh Anakinra for rheumatoid arthritis Cochrane Database Syst Rev 1 2009 CD005121
70. B. Bresnihan The safety and efficacy of interleukin-1 receptor antagonist in the treatment of rheumatoid arthritis Semin Arthritis Rheum 30 5 Suppl. 2 2001 17 20 (Pubitemid 32467131)
71. R.M. Fleischmann, J. Schechtman, R. Bennett, M.L. Handel, G.R. Burmester, and J. Tesser Anakinra, a recombinant human interleukin-1 receptor antagonist (r-metHuIL-1ra), in patients with rheumatoid arthritis: a large, international, multicenter, placebo-controlled trial Arthritis Rheum 48 4 2003 927 934 (Pubitemid 36418234)
72. R.M. Fleischmann, J. Tesser, M.H. Schiff, J. Schechtman, G.R. Burmester, and R. Bennett Safety of extended treatment with anakinra in patients with rheumatoid arthritis Ann Rheum Dis 65 8 2006 1006 1012 (Pubitemid 44133261)
73. A.M. Owyang, H. Issafras, J. Corbin, K. Ahluwalia, P. Larsen, and E. Pongo XOMA 052, a potent, high-affinity monoclonal antibody for the treatment of IL-1beta-mediated diseases MAbs 3 1 2011 49 60
74. A. Askanase, K. Shum, and H. Mitnick Systemic lupus erythematosus: an overview Soc Work Health Care 51 7 2012 576 586
75. G.S. Dean, J. Tyrrell-Price, E. Crawley, and D.A. Isenberg Cytokines and systemic lupus erythematosus Ann Rheum Dis 59 4 2000 243 251 (Pubitemid 30305564)
76. R.C. Jandl, J.L. George, C.A. Dinarello, and P.H. Schur The effect of interleukin 1 on IgG synthesis in systemic lupus erythematosus Clin Immunol Immunopathol 45 3 1987 384 394 (Pubitemid 18005916)
77. R. Segal, B.L. Bermas, M. Dayan, F. Kalush, G.M. Shearer, and E. Mozes Kinetics of cytokine production in experimental systemic lupus erythematosus: involvement of T helper cell 1/T helper cell 2-type cytokines in disease J Immunol 158 6 1997 3009 3016 (Pubitemid 127470564)
78. B.S. Handwerger, V. Rus, L. da Silva, and C.S. Via The role of cytokines in the immunopathogenesis of lupus Springer Semin Immunopathol 16 2-3 1994 153 180
79. M. Aringer, and J.S. Smolen Cytokine expression in lupus kidneys Lupus 14 1 2005 13 18 (Pubitemid 40216062)
80. D.C. Brennan, M.A. Yui, R.P. Wuthrich, and V.E. Kelley Tumor necrosis factor and IL-1 in New Zealand Black/White mice. Enhanced gene expression and acceleration of renal injury J Immunol 143 11 1989 3470 3475 (Pubitemid 20007007)
81. E. Voronov, M. Dayan, H. Zinger, L. Gayvoronsky, J.P. Lin, and Y. Iwakura IL-1 beta-deficient mice are resistant to induction of experimental SLE Eur Cytokine Netw 17 2 2006 109 116
82. J.J. Connolly, and H. Hakonarson Role of cytokines in systemic lupus erythematosus: recent progress from GWAS and sequencing J Biomed Biotechnol 2012 2012 798924
83. H. Suzuki, H. Takemura, and H. Kashiwagi Interleukin-1 receptor antagonist in patients with active systemic lupus erythematosus. Enhanced production by monocytes and correlation with disease activity Arthritis Rheum 38 8 1995 1055 1059
84. G. Sturfelt, P. Roux-Lombard, F.A. Wollheim, and J.M. Dayer Low levels of interleukin-1 receptor antagonist coincide with kidney involvement in systemic lupus erythematosus Br J Rheumatol 36 12 1997 1283 1289
85. W.W. Lee, N. Lee, H. Fujii, and I. Kang Active hexose correlated compound promotes T helper (Th) 17 and 1 cell responses via inducing IL-1beta production from monocytes in humans Cell Immunol 275 1-2 2012 19 23
86. D. Zoukhri, E. Macari, S.H. Choi, and C.L. Kublin c-Jun NH2-terminal kinase mediates interleukin-1beta-induced inhibition of lacrimal gland secretion J Neurochem 96 1 2006 126 135
87. R.I. Fox, J. Tornwall, and P. Michelson Current issues in the diagnosis and treatment of Sjogren's syndrome Curr Opin Rheumatol 11 5 1999 364 371
88. P. Willeke, H. Schotte, B. Schluter, M. Erren, H. Becker, and A. Dyong Interleukin 1beta and tumour necrosis factor alpha secreting cells are increased in the peripheral blood of patients with primary Sjogren's syndrome Ann Rheum Dis 62 4 2003 359 362 (Pubitemid 36363446)
89. N.I. Tapinos, M. Polihronis, A.G. Tzioufas, and H.M. Moutsopoulos Sjogren's syndrome. Autoimmune epithelitis Adv Exp Med Biol 455 1999 127 134
90. M. Azuma, K. Motegi, K. Aota, Y. Hayashi, and M. Sato Role of cytokines in the destruction of acinar structure in Sjogren's syndrome salivary glands Lab Investig; J Tech Methods Pathol 77 3 1997 269 280 (Pubitemid 27413539)
91. M. Garcic-Carrasco, J. Font, X. Filella, R. Cervera, M. Ramos-Casals, and A. Siso Circulating levels of Th1/Th2 cytokines in patients with primary Sjogren's syndrome: correlation with clinical and immunological features Clin Exp Rheumatol 19 4 2001 411 415 (Pubitemid 32685367)
92. C. Beauregard, P.C. Brandt, and G.C. Chiou Induction of nitric oxide synthase and over-production of nitric oxide by interleukin-1beta in cultured lacrimal gland acinar cells Exp Eye Res 77 1 2003 109 114 (Pubitemid 36776280)
93. M. Yamakawa, R. Weinstein, T. Tsuji, J. McBride, D.T. Wong, and G.R. Login Age-related alterations in IL-1beta, TNF-alpha, and IL-6 concentrations in parotid acinar cells from BALB/c and non-obese diabetic mice J Histochem Cytochem 48 8 2000 1033 1042
94. P. Szodoray, P. Alex, J.G. Brun, M. Centola, and R. Jonsson Circulating cytokines in primary Sjogren's syndrome determined by a multiplex cytokine array system Scand J Immunol 59 6 2004 592 599 (Pubitemid 38789229)
95. Y. Muraki, A. Tsutsumi, R. Takahashi, E. Suzuki, T. Hayashi, and Y. Chino Polymorphisms of IL-1 beta gene in Japanese patients with Sjogren's syndrome and systemic lupus erythematosus J Rheumatol 31 4 2004 720 725 (Pubitemid 38451258)
96. D. Zoukhri, R.R. Hodges, D. Byon, and C.L. Kublin Role of proinflammatory cytokines in the impaired lacrimation associated with autoimmune xerophthalmia Invest Ophthalmol Vis Sci 43 5 2002 1429 1436 (Pubitemid 34462641)
97. H. Becker, H. Pavenstaedt, and P. Willeke Emerging treatment strategies and potential therapeutic targets in primary Sjogren's syndrome Inflamm Allergy Drug Targets 9 1 2010 10 19
98. D. Lasiglie, E. Traggiai, S. Federici, M. Alessio, A. Buoncompagni, and A. Accogli Role of IL-1 beta in the development of human T(H)17 cells: lesson from NLPR3 mutated patients PLoS One 6 5 2011 e20014
99. W. Chi, P. Yang, B. Li, C. Wu, H. Jin, and X. Zhu IL-23 promotes CD4 + T cells to produce IL-17 in Vogt-Koyanagi-Harada disease J Allergy Clin Immunol 119 5 2007 1218 1224 (Pubitemid 46667160)
100. A. Amadi-Obi, C.R. Yu, X. Liu, R.M. Mahdi, G.L. Clarke, and R.B. Nussenblatt TH17 cells contribute to uveitis and scleritis and are expanded by IL-2 and inhibited by IL-27/STAT1 Nat Med 13 6 2007 711 718 (Pubitemid 46889754)
101. J. Karasneh, A.H. Hajeer, J. Barrett, W.E. Ollier, M. Thornhill, and A. Gul Association of specific interleukin 1 gene cluster polymorphisms with increased susceptibility for Behcet's disease Rheumatology (Oxford) 42 7 2003 860 864 (Pubitemid 37220935)
102. S.B. Su, P.B. Silver, R.S. Grajewski, R.K. Agarwal, J. Tang, and C.C. Chan Essential role of the MyD88 pathway, but nonessential roles of TLRs 2, 4, and 9, in the adjuvant effect promoting Th1-mediated autoimmunity J Immunol 175 10 2005 6303 6310 (Pubitemid 41598869)
103. S. Pay, H. Erdem, A. Pekel, I. Simsek, U. Musabak, and A. Sengul Synovial proinflammatory cytokines and their correlation with matrix metalloproteinase-3 expression in Behcet's disease. Does interleukin-1beta play a major role in Behcet's synovitis? Rheumatol Int 26 7 2006 608 613
104. B. Xuan, G.C. Chiou, Z. Chen, T. Yamasaki, and T. Okawara Effective treatment of experimental uveitis with interleukin-1 blockers, CK 123 and CK 124 J Ocul Pharmacol Ther 14 1 1998 31 44 (Pubitemid 28081341)
105. N. Duzgun, E. Ayaslioglu, H. Tutkak, and O.T. Aydintug Cytokine inhibitors: soluble tumor necrosis factor receptor 1 and interleukin-1 receptor antagonist in Behcet's disease Rheumatol Int 25 1 2005 1 5
106. A. Gul, I. Tugal-Tutkun, C.A. Dinarello, L. Reznikov, B.A. Esen, and A. Mirza Interleukin-1beta-regulating antibody XOMA 052 (gevokizumab) in the treatment of acute exacerbations of resistant uveitis of Behcet's disease: an open-label pilot study Ann Rheum Dis 71 4 2012 563 566
107. H. Keino Therapeutic effect of the low molecular weight inhibitor of the NF-kappaB signaling pathway on experimental autoimmune uveoretinitis Nihon Ganka Gakkai Zasshi 114 11 2010 944 954
108. H. Kitamei, K. Iwabuchi, K. Namba, K. Yoshida, Y. Yanagawa, and N. Kitaichi Amelioration of experimental autoimmune uveoretinitis (EAU) with an inhibitor of nuclear factor-kappaB (NF-kappaB), pyrrolidine dithiocarbamate J Leukoc Biol 79 6 2006 1193 1201 (Pubitemid 44835553)
109. A. Lennikov, N. Kitaichi, K. Noda, R. Ando, Z. Dong, and J. Fukuhara Amelioration of endotoxin-induced uveitis treated with an IkappaB kinase beta inhibitor in rats Mol Vis 18 2012 2586 2597
110. S. Ugurlu, D. Ucar, E. Seyahi, G. Hatemi, and S. Yurdakul Canakinumab in a patient with juvenile Behcet's syndrome with refractory eye disease Ann Rheum Dis 71 9 2012 1589 1591
111. I. Kone-Paut, H.J. Lachmann, J.B. Kuemmerle-Deschner, E. Hachulla, K.S. Leslie, and R. Mouy Sustained remission of symptoms and improved health-related quality of life in patients with cryopyrin-associated periodic syndrome treated with canakinumab: results of a double-blind placebo-controlled randomized withdrawal study Arthritis Res Ther 13 6 2011 R202
112. A.P. Weetman The potential immunological role of the thyroid cell in autoimmune thyroid disease Thyroid 4 4 1994 493 499
113. S.A. Rebuffat, M. Kammoun-Krichen, I. Charfeddine, H. Ayadi, N. Bougacha-Elleuch, and S. Peraldi-Roux IL-1beta and TSH disturb thyroid epithelium integrity in autoimmune thyroid diseases Immunobiology 218 3 2013 285 291
114. F. Paolieri, C. Salmaso, M. Battifora, P. Montagna, G. Pesce, and M. Bagnasco Possible pathogenetic relevance of interleukin-1 beta in "destructive" organ-specific autoimmune disease (Hashimoto's thyroiditis) Ann N Y Acad Sci 876 1999 221 228 (Pubitemid 29352129)
115. V. Naik, N. Khadavi, M.N. Naik, C. Hwang, R.A. Goldberg, and A. Tsirbas Biologic therapeutics in thyroid-associated ophthalmopathy: translating disease mechanism into therapy Thyroid 18 9 2008 967 971
116. J.A. Garrity, and R.S. Bahn Pathogenesis of graves ophthalmopathy: implications for prediction, prevention, and treatment Am J Ophthalmol 142 1 2006 147 153
117. R. Han, and T.J. Smith Induction by IL-1 beta of tissue inhibitor of metalloproteinase-1 in human orbital fibroblasts: modulation of gene promoter activity by IL-4 and IFN-gamma J Immunol 174 5 2005 3072 3079 (Pubitemid 40279729)
118. R. Lu, P. Wang, L. Wartofsky, B.D. Sutton, J.L. Zweier, and R.S. Bahn Oxygen free radicals in interleukin-1beta-induced glycosaminoglycan production by retro-ocular fibroblasts from normal subjects and Graves' ophthalmopathy patients Thyroid 9 3 1999 297 303 (Pubitemid 29171781)
119. D. Huang, N. Xu, Y. Song, P. Wang, and H. Yang Inflammatory cytokine profiles in the tears of thyroid-associated ophthalmopathy Graefes Arch Clin Exp Ophthalmol 250 4 2012 619 625
120. H.S. Jun, and J.W. Yoon Initiation of autoimmune type 1 diabetes and molecular cloning of a gene encoding for islet cell-specific 37kd autoantigen Adv Exp Med Biol 347 1994 207 220
121. J.A. Corbett, G. Kwon, M.H. Marino, C.P. Rodi, P.M. Sullivan, and J. Turk Tyrosine kinase inhibitors prevent cytokine-induced expression of iNOS and COX-2 by human islets Am J Physiol 270 6 Pt 1 1996 C1581 C1587
122. Y. Dogan, S. Akarsu, B. Ustundag, E. Yilmaz, and M.K. Gurgoze Serum IL-1beta, IL-2, and IL-6 in insulin-dependent diabetic children Mediators Inflamm 2006 1 2006 59206
123. J.A. Corbett, G. Kwon, J. Turk, and M.L. McDaniel IL-1 beta induces the coexpression of both nitric oxide synthase and cyclooxygenase by islets of Langerhans: activation of cyclooxygenase by nitric oxide Biochemistry 32 50 1993 13767 13770
124. A. Rabinovitch An update on cytokines in the pathogenesis of insulin-dependent diabetes mellitus Diabetes Metab Rev 14 2 1998 129 151 (Pubitemid 28346261)
125. S. Reddy, and M. Young IL-1beta expression in islet cells of the NOD mouse and its spatial relationship to beta cells and inducible nitric oxide synthase Ann N Y Acad Sci 958 2002 190 193 (Pubitemid 34592225)
126. A.M. Sprinkel, N.A. Andersen, and T. Mandrup-Poulsen Glucose potentiates interleukin-1 beta (IL-1 beta)-induced p38 mitogen-activated protein kinase activity in rat pancreatic islets of Langerhans Eur Cytokine Netw 12 2 2001 331 339 (Pubitemid 32530392)
127. E.S. Xenos, R.B. Stevens, P.F. Gores, D. Casanova, A.C. Farney, and D.E. Sutherland IL-1 beta-induced inhibition of beta-cell function is mediated through nitric oxide Transplant Proc 25 1 Pt 2 1993 994 (Pubitemid 23078872)
128. S. Baekkeskov, H.J. Aanstoot, S. Christgau, A. Reetz, M. Solimena, and M. Cascalho Identification of the 64 K autoantigen in insulin-dependent diabetes as the GABA-synthesizing enzyme glutamic acid decarboxylase Nature 347 6289 1990 151 156
129. R.S. Schmidli, B.E. Faulkner-Jones, L.C. Harrison, R.F. James, and H.J. DeAizpurua Cytokine regulation of glutamate decarboxylase biosynthesis in isolated rat islets of Langerhans Biochem J 317 Pt 3 1996 713 719
130. N. Giannoukakis, W.A. Rudert, M. Trucco, and P.D. Robbins Protection of human islets from the effects of interleukin-1beta by adenoviral gene transfer of an Ikappa B repressor J Biol Chem 275 47 2000 36509 36513 (Pubitemid 32002047)
131. F. Ortis, P. Pirot, N. Naamane, A.Y. Kreins, J. Rasschaert, and F. Moore Induction of nuclear factor-kappaB and its downstream genes by TNF-alpha and IL-1beta has a pro-apoptotic role in pancreatic beta cells Diabetologia 51 7 2008 1213 1225
132. F. Ortis, M. Miani, M.L. Colli, D.A. Cunha, E.N. Gurzov, and F. Allagnat Differential usage of NF-kappaB activating signals by IL-1beta and TNF-alpha in pancreatic beta cells FEBS Lett 586 7 2012 984 989
133. C.A. Wilson, C. Jacobs, P. Baker, D.G. Baskin, S. Dower, and A. Lernmark IL-1 beta modulation of spontaneous autoimmune diabetes and thyroiditis in the BB rat J Immunol 144 10 1990 3784 3788 (Pubitemid 20171186)
134. C. Cailleau, A. Diu-Hercend, E. Ruuth, R. Westwood, and C. Carnaud Treatment with neutralizing antibodies specific for IL-1beta prevents cyclophosphamide-induced diabetes in nonobese diabetic mice Diabetes 46 6 1997 937 940 (Pubitemid 27220991)
135. K.M. Sumpter, S. Adhikari, E.K. Grishman, and P.C. White Preliminary studies related to anti-interleukin-1beta therapy in children with newly diagnosed type 1 diabetes Pediatr Diabetes 12 7 2011 656 667
136. B.F. McCabe Autoimmune sensorineural hearing loss Ann Otol Rhinol Laryngol 88 5 Pt 1 1979 585 589 (Pubitemid 10249251)
137. C.A. Solares, A.E. Edling, J.M. Johnson, M.J. Baek, K. Hirose, and G.B. Hughes Murine autoimmune hearing loss mediated by CD4 + T cells specific for inner ear peptides J Clin Invest 113 8 2004 1210 1217 (Pubitemid 38544106)
138. M.J. Ruckenstein Autoimmune inner ear disease Curr Opin Otolaryngol Head Neck Surg 12 5 2004 426 430 (Pubitemid 39287572)
139. B.D. Trapp, L. Bo, S. Mork, and A. Chang Pathogenesis of tissue injury in MS lesions J Neuroimmunol 98 1 1999 49 56 (Pubitemid 29295407)
140. L.G. Filion, G. Graziani-Bowering, D. Matusevicius, and M.S. Freedman Monocyte-derived cytokines in multiple sclerosis Clin Exp Immunol 131 2 2003 324 334 (Pubitemid 36205147)
141. A.E. Lovett-Racke, Y. Yang, and M.K. Racke Th1 versus Th17: are T cell cytokines relevant in multiple sclerosis? Biochim Biophys Acta 1812 2 2011 246 251
142. B.M. Segal Th17 cells in autoimmune demyelinating disease Semin Immunopathol 32 1 2010 71 77
143. R.F. Madera, J.P. Wang, and D.H. Libraty The combination of early and rapid type I IFN, IL-1alpha, and IL-1beta production are essential mediators of RNA-like adjuvant driven CD4 + Th1 responses PLoS One 6 12 2011 e29412
144. B. Cannella, and C.S. Raine The adhesion molecule and cytokine profile of multiple sclerosis lesions Ann Neurol 37 4 1995 424 435
145. I. Huitinga, M. van der Cammen, L. Salm, Z. Erkut, A. van Dam, and F. Tilders IL-1beta immunoreactive neurons in the human hypothalamus: reduced numbers in multiple sclerosis J Neuroimmunol 107 1 2000 8 20 (Pubitemid 30243126)
146. V. Badovinac, M. Mostarica-Stojkovic, C.A. Dinarello, and S. Stosic-Grujicic Interleukin-1 receptor antagonist suppresses experimental autoimmune encephalomyelitis (EAE) in rats by influencing the activation and proliferation of encephalitogenic cells J Neuroimmunol 85 1 1998 87 95 (Pubitemid 28255441)
147. F. Nicoletti, F. Patti, R. DiMarco, P. Zaccone, A. Nicoletti, and P. Meroni Circulating serum levels of IL-1ra in patients with relapsing remitting multiple sclerosis are normal during remission phases but significantly increased either during exacerbations or in response to IFN-beta treatment Cytokine 8 5 1996 395 400
148. M. Matsuda, N. Tsukada, K. Miyagi, and N. Yanagisawa Increased interleukin-1 production by peripheral blood mononuclear cells in patients with multiple sclerosis J Neurol Sci 102 1 1991 100 104
149. H. Futamatsu, J. Suzuki, H. Kosuge, O. Yokoseki, M. Kamada, and H. Ito Attenuation of experimental autoimmune myocarditis by blocking activated T cells through inducible costimulatory molecule pathway Cardiovasc Res 59 1 2003 95 104 (Pubitemid 36776376)
150. M. Kodama, Y. Matsumoto, M. Fujiwara, F. Masani, T. Izumi, and A. Shibata A novel experimental model of giant cell myocarditis induced in rats by immunization with cardiac myosin fraction Clin Immunol Immunopathol 57 2 1990 250 262 (Pubitemid 20368038)
151. N.R. Paleev, F.N. Paleev, S.V. Suchkov, A.N. Kotova, and O.A. Pronina Cytokines as a diagnostic and therapeutic tool in patients with myocarditis Vestn Ross Akad Med Nauk 5 2005 8 13 (Pubitemid 40828694)
152. D.J. Ing, J. Zang, V.J. Dzau, K.A. Webster, and N.H. Bishopric Modulation of cytokine-induced cardiac myocyte apoptosis by nitric oxide, Bak, and Bcl-x Circ Res 84 1 1999 21 33 (Pubitemid 29074877)
153. N.R. Rose Critical cytokine pathways to cardiac inflammation J Interferon Cytokine Res 31 10 2011 705 710
154. A. Matsumori, T. Yamada, H. Suzuki, Y. Matoba, and S. Sasayama Increased circulating cytokines in patients with myocarditis and cardiomyopathy Br Heart J 72 6 1994 561 566
155. Y. Matsui, M. Inobe, H. Okamoto, S. Chiba, T. Shimizu, and A. Kitabatake Blockade of T cell costimulatory signals using adenovirus vectors prevents both the induction and the progression of experimental autoimmune myocarditis J Mol Cell Cardiol 34 3 2002 279 295 (Pubitemid 37162421)
156. H. Zhang, Y. Song, and Z. Zhang Glycyrrhizin administration ameliorates coxsackievirus B3-induced myocarditis in mice Am J Med Sci 344 3 2012 206 210
157. S. Mito, K. Watanabe, M. Harima, R.A. Thandavarayan, P.T. Veeraveedu, and V. Sukumaran Curcumin ameliorates cardiac inflammation in rats with autoimmune myocarditis Biol Pharm Bull 34 7 2011 974 979
158. B. Stein, P. Frank, W. Schmitz, H. Scholz, and M. Thoenes Endotoxin and cytokines induce direct cardiodepressive effects in mammalian cardiomyocytes via induction of nitric oxide synthase J Mol Cell Cardiol 28 8 1996 1631 1639 (Pubitemid 26300563)
159. O. Yokoseki, J. Suzuki, H. Kitabayashi, N. Watanabe, Y. Wada, and M. Aoki cis Element decoy against nuclear factor-kappaB attenuates development of experimental autoimmune myocarditis in rats Circ Res 89 10 2001 899 906 (Pubitemid 34627895)
160. L. Zhao, Y. Tang, Z. You, Q. Wang, S. Liang, and X. Han Interleukin-17 contributes to the pathogenesis of autoimmune hepatitis through inducing hepatic interleukin-6 expression PLoS One 6 4 2011 e18909
161. A. Makol, K.D. Watt, and V.R. Chowdhary Autoimmune hepatitis: a review of current diagnosis and treatment Hepat Res. Treat. 2011 2011 390916
162. O. Devergne, M. Peuchmaur, M. Humbert, E. Navratil, M.B. Leger-Ravet, and M.C. Crevon In vivo expression of IL-1 beta and IL-6 genes during viral infections in human Eur Cytokine Netw 2 3 1991 183 194
163. M. Shindo, G.E. Mullin, L. Braun-Elwert, N.V. Bergasa, E.A. Jones, and S.P. James Cytokine mRNA expression in the liver of patients with primary biliary cirrhosis (PBC) and chronic hepatitis B (CHB) Clin Exp Immunol 105 2 1996 254 259 (Pubitemid 26246942)
164. Z. Tian, X. Shen, H. Feng, and B. Gao IL-1 beta attenuates IFN-alpha beta-induced antiviral activity and STAT1 activation in the liver: involvement of proteasome-dependent pathway J Immunol 165 7 2000 3959 3965 (Pubitemid 32057305)
165. S. Satoh, A.K. Nussler, Z.Z. Liu, and A.W. Thomson Proinflammatory cytokines and endotoxin stimulate ICAM-1 gene expression and secretion by normal human hepatocytes Immunology 82 4 1994 571 576 (Pubitemid 24263383)
166. D.H. Adams, E. Mainolfi, P. Burra, J.M. Neuberger, R. Ayres, and E. Elias Detection of circulating intercellular adhesion molecule-1 in chronic liver diseases Hepatology 16 3 1992 810 814
167. A.W. Thomson, S. Satoh, A.K. Nussler, K. Tamura, J. Woo, and J. Gavaler Circulating intercellular adhesion molecule-1 (ICAM-1) in autoimmune liver disease and evidence for the production of ICAM-1 by cytokine-stimulated human hepatocytes Clin Exp Immunol 95 1 1994 83 90 (Pubitemid 24207108)
168. R. Liberal, C.R. Grant, G. Mieli-Vergani, and D. Vergani Autoimmune hepatitis: a comprehensive review J Autoimmun 41 2013 126 139
169. M. Geneva-Popova, and M. Murdjeva Study on proinflammatory cytokines (IL-1 beta, IL-6, TNF-alpha) and IL-2 in patients with acute hepatitis B Folia Med (Plovdiv) 41 1 1999 78 81
170. J.J. Carrero, S.H. Park, J. Axelsson, B. Lindholm, and P. Stenvinkel Cytokines, atherogenesis, and hypercatabolism in chronic kidney disease: a dreadful triad Semin Dial 22 4 2009 381 386
171. K. Kilis-Pstrusinska Genetic factors in the development and progression of chronic kidney disease Postepy Hig Med Dosw (Online) 64 2010 50 57
172. S. Zyga, G. Christopoulou, and M. Malliarou Malnutrition-inflammation- atherosclerosis syndrome in patients with end-stage renal disease J Ren Care 37 1 2011 12 15
173. Y. Xia, L. Feng, T. Yoshimura, and C.B. Wilson LPS-induced MCP-1, IL-1 beta, and TNF-alpha mRNA expression in isolated erythrocyte-perfused rat kidney Am J Physiol 264 5 Pt 2 1993 F774 F780
174. N.H. Cartwright, L.J. Keen, A.G. Demaine, N.J. Hurlock, R.J. McGonigle, and P.A. Rowe A study of cytokine gene polymorphisms and protein secretion in renal transplantation Transpl Immunol 8 4 2001 237 244 (Pubitemid 32249011)
175. E. Rodrigo, P. Sanchez-Velasco, J.C. Ruiz, G. Fernandez-Fresnedo, M. Lopez-Hoyos, and C. Pinera Cytokine polymorphisms and risk of infection after kidney transplantation Transplant Proc 39 7 2007 2219 2221 (Pubitemid 47418160)
176. Q.Q. Wan, Q.F. Ye, Y. Ma, and J.D. Zhou Genetic association of interleukin-1beta (-511C/T) and its receptor antagonist (86-bpVNTR) gene polymorphism with susceptibility to bacteremia in kidney transplant recipients Transplant Proc 44 10 2012 3026 3028
177. M. Berry, and M.R. Clatworthy Immunotherapy for acute kidney injury Immunotherapy 4 3 2012 323 334
178. H.J. Shao, L. Chen, M.S. Shen, and G.F. Yu Enhancement of immune responses to the hepatitis B virus core protein through DNA vaccines with a DNA fragment encoding human IL-1beta 163-171 peptide Acta Virol 47 4 2003 217 221 (Pubitemid 38186084)
179. C.A. Dinarello, A. Simon, and J.W. van der Meer Treating inflammation by blocking interleukin-1 in a broad spectrum of diseases Nat Rev Drug Discov 11 8 2012 633 652
180. J. Kong, S.A. Grando, and Y.C. Li Regulation of IL-1 family cytokines IL-1alpha, IL-1 receptor antagonist, and IL-18 by 1,25-dihydroxyvitamin D3 in primary keratinocytes J Immunol 176 6 2006 3780 3787 (Pubitemid 43364026)
181. C.T. Jayasuriya, M.B. Goldring, R. Terek, and Q. Chen Matrilin-3 Induction of IL-1 receptor antagonist is required for up-regulating collagen II and aggrecan and down-regulating ADAMTS-5 gene expression Arthritis Res Ther 14 5 2012 R197
182. D. Prefontaine, S. Lajoie-Kadoch, S. Foley, S. Audusseau, R. Olivenstein, and A.J. Halayko Increased expression of IL-33 in severe asthma: evidence of expression by airway smooth muscle cells J Immunol 183 8 2009 5094 5103
183. M.F. Nold, C.A. Nold-Petry, J.A. Zepp, B.E. Palmer, P. Bufler, and C.A. Dinarello IL-37 is a fundamental inhibitor of innate immunity Nat Immunol 11 11 2010 1014 1022
184. R. Essner, K. Rhoades, W.H. McBride, D.L. Morton, and J.S. Economou IL-4 down-regulates IL-1 and TNF gene expression in human monocytes J Immunol 142 11 1989 3857 3861 (Pubitemid 19164414)
185. P.J. Murray, and S.T. Smale Restraint of inflammatory signaling by interdependent strata of negative regulatory pathways Nat Immunol 13 10 2012 916 924
186. Y. Yang, E. Hahm, Y. Kim, J. Kang, W. Lee, and I. Han Regulation of IL-18 expression by CRH in mouse microglial cells Immunol Lett 98 2 2005 291 296 (Pubitemid 40602642)
187. Y. Carrier, H.L. Ma, H.E. Ramon, L. Napierata, C. Small, and M. O'Toole Inter-regulation of Th17 cytokines and the IL-36 cytokines in vitro and in vivo: implications in psoriasis pathogenesis J Invest Dermatol 131 12 2011 2428 2437